When Is It Appropriate to Stop Non-vitamin K Antagonist Oral Anticoagulants before Catheter Ablation of Atrial Fibrillation? A Multicentre Prospective Randomized Study
[Speaker] Hee Tae Yu/Yonsei Univ.,Korea
Critique
[Speaker] Seongwook Han/Keimyung Univ.,Korea
Discussion
Outcomes of Direct Oral Anticoagulants in Patients with Mitral Stenosis
[Speaker] Ju Youn Kim/Catholic Univ.,Korea
Critique
[Speaker] Eue-Keun Choi/Seoul National Univ.,Korea
Discussion
Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Low Body Weight
[Speaker] So-Ryoung Lee/Seoul National Univ.,Korea
Critique
[Speaker] Jong-Il Choi/Korea Univ.,Korea
Discussion
Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial
[Speaker] Jae-Kwan Song/Ulsan Univ.,Korea
Critique
[Speaker] Jae Hyung Park/Korea Univ.,Korea
Discussion
P2Y12 Inhibitor Monotherapy versus Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention The SMART-CHOICE Randomized, Open-label, Noninferiority Trial
[Speaker] Joo-Yong Hahn/Sungkyunkwan Univ.,Korea
Critique
[Speaker] Jung Rae Cho/Hallym Univ.,Korea
Discussion
Deferred vs. Performed Revascularization for Coronary Stenosis with Grey-zone Fractional Flow Reserve Values: Data from the IRIS-FFR Registry
[Speaker] Do-Yoon Kang/Ulsan Univ.,Korea
Critique
[Speaker] Myeong-Ho Yoon/Ajou Univ.,Korea
Discussion